Tag: Zydus Lifesciences
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following the final approval from the United States ... Read More
Zydus Lifesciences announces WHO approval for NLRP3 inhibitor Usnoflast
Zydus Lifesciences, a discovery-based, global pharmaceutical leader, has recently received approval from the World Health Organization (WHO) International Non-proprietary Names (INN) for "Usnoflast" as the ... Read More
Zydus Lifesciences gains FDA aproval for Chlorpromazine Hydrochloride Injection
In a notable development for the pharmaceutical industry, Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has received final approval from the United States ... Read More
Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More
Zydus Lifesciences achieves WHO prequalification for Leishmaniasis treatment, Miltefosine
Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has achieved a significant milestone in global healthcare by receiving the World Health Organization (WHO) ... Read More
Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules
Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the United States Food and Drug Administration (USFDA) ... Read More
Zydus Lifesciences to launch Phase 2 Parkinson’s disease trial of ZYIL1
Zydus Lifesciences Limited, a globally recognized pharmaceutical company, has recently obtained the USFDA's approval to commence Phase II clinical study of its NLRP3 inhibitor, ZYIL1, ... Read More
Zydus Lifesciences bags FDA approval for Lacosamide Tablets in seizures
Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has recently received final approval from the United States Food and Drug Administration (USFDA) to ... Read More
Zydus Lifesciences gains FDA approval for Darunavir Tablets in HIV-1 treatment
Zydus Lifesciences Limited, a prominent name in the global pharmaceutical industry, has achieved a significant milestone with the United States Food and Drug Administration (FDA) ... Read More
Zydus Lifesciences, Daewoong Pharmaceutical forge US market alliance for Leuprolide Acetate
Zydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd., and South Korea's Daewoong Pharmaceutical Co., Ltd. have entered into a significant exclusive licensing agreement. ... Read More